GRDNGuardian Pharmacy Services, Inc.
Is the business good?
The checks split: nothing decisive, though earnings fully cash-backed (1.7×).
Operating profit is fully backed by cash.
Efficiency-driven, thin margins turned over fast (the retail model). ROE 23% = margin × turnover × leverage.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is GRDN?
Guardian Pharmacy Services, Inc. earns 40% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.
Return on invested capital · cost of capital 9.0% · 31 points above what the capital costs: growth creates value
- Operating margin
- 5.8%
Operating margin · Medical Care Facilities median 9.3% · 12 months to Q2 2026
- Cash conversion
- 1.67×
Cash conversion · operating cash flow covers the operating profit after tax
- Gross margin
- 22%
Gross margin
Details›
- Gross margin12 months to Q2 2026
- 22%
- Operating margin12 months to Q2 2026
- 5.8%
- Net margin12 months to Q2 2026
- 4.5%
- Revenue, trailing twelve months
- $1.46B
- Net income, trailing twelve months
- $66M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 40%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Medical Care Facilities
The closest names by size in the same industry